We synthesized 16 pyrrolidine-based oxy-peptide nucleic acid (POPNA) monomers carrying four different nucleobases onto four different stereoisomers of pyrrolidine rings. Using these monomers, we prepared POPNA oligomers, which formed sequence-specific hybrids with DNAs. The oligomer configurations influenced the hybrid stability. The oligomers were not taken into CHO cells. However, they could enter the cell cytoplasm when mixed with the influenza virus hemagglutinin peptide-arginine heptamer conjugate.
Introduction
Nielsen-type peptide nucleic acids (PNAs; Figure 1 A) are DNA surrogates that form stable duplexes and triplexes with DNAs (Figure 1 B) and RNAs. 1 The non-ionic backbone of PNAs leads to stable hybrids with the nucleic acids, but at the same time, the neutral backbone results in low water solubility of the PNAs owing to the formation of aggregates in aqueous solutions. This undesirable property limits the use of PNAs in medicinal and other applications. One way of overcoming this drawback is to conjugate PNAs with cationic peptides such as cell-penetrating peptides (CPPs).
2 However, the PNA-CPP conjugates cause non-specific interactions with nucleic acids consisting of anionic backbones.
To overcome these drawbacks, we synthesized new peptide nucleic acids by introducing ether linkages in the main chain of peptide nucleic acids; An example is oxy-PNA (OPNA; Figure 1 C) . 3 Introduction of ether linkages in the PNA backbones can improve the water solubility of the PNAs. 3a, 4 OPNAs are also not expected to non-specifically interact with nucleic acids because of the non-ionic backbone of the OPNAs. The OPNA oligomers can be successfully hybridized with the complementary DNAs, which is indicated by very sharp melting curves. However, because OPNAs do not form stable hybrids with RNAs, we designed and synthesized other types of oxy-PNAs that whose structures resembled the structure of DNA by introducing pyrrolidine rings in the backbone; An example is pyrrolidinebased oxy-PNAs (POPNAs; Figure 1 The pyrrolidine ring possesses two chiral centers and there are four stereoisomers (cis-L-, trans-L-, cis-D-, and trans-Dconfigurations) . We have previously shown that among the adenine homo-oligomers of the four different configurations, trans-L-POPNA and cis-L-POPNA form the most stable hybrids with the complementary RNA and DNA, respectively. 5d In this study, we synthesized sixteen POPNA monomers of four stereoisomers on the pyrrolidine ring with four different nucleobases (adenine (A), thymine (T), guanine (G), and cytosine (C)). The coupling of these monomers resulted in the synthesis of POPNA oligomers that contained sequences of the four nucleobases. The coupling was performed by Fmoc-based solidphase peptide synthesis (SPPS). The formation of hybrids of these POPNA oligomers with the DNA sequences was examined by studying the melting curves. We also investigated the cellular uptake and endosomal release of the POPNA oligomers. The cellular uptake of POPNA oligomers was achieved by mixing the POPNA oligomers with HA2 (an N-terminal 23-mer peptide of the influenza virus hemagglutinin protein) 7 conjugated with a CPP consisting of an arginine heptamer. 
Results and discussion

Synthesis of POPNA monomers and their oligomers
Sixteen POPNA monomers were synthesized from two compounds, 1 (the trans-L-1, see Scheme 1) and the cis-D-1. These starting materials, 1 and the cis-D-1, were synthesized from trans-L-hydroxyproline and cis-D-hydroxyproline in 6 steps according to the literature procedure, respectively.
5b Cis-L-2 and trans-D-2 were synthesized in two steps through the inversion of the free hydroxyl group-in the 4 th position of the pyrrolidine ring of trans-L-1 and cis-D-1-by formylation and subsequent treatment with aqueous ammonia in methanol. The synthetic routes from the compound 2 to the trans-L-POPNA monomers with A, T, G, and C nucleobases are shown in Scheme 1.
For preparing the trans-L-POPNA T monomer, first, compound 3 was synthesized by a direct substitution of the hydroxyl group of 2 with N 3 -benzoylthymine 9 under Mitsunobu conditions. 5,10 Next, 3 was treated with 30% HBr/AcOH to remove the tert-butyloxycarbonyl (Boc), tert-butyl ester (tBu), and benzoyl (Bz) protecting groups. The resulting free amine was then protected with 9-fluorenylmethyl succinimidyl carbonate (Fmoc-OSu) to give the trans-L-POPNA T monomer 4 in an overall yield of 85% from 2. For the trans-L-POPNA A monomer, the hydroxyl group of 2 was first reacted with methanesulfonyl chloride (Ms-Cl) to give the mesylate 5 in 90% yield. Next, 5 was alkylated with N 6 -benzoyladenine to give compound 6 in 55% yield. 11 Removal of Boc, tBu, and Bz protecting groups on 6 with 30% HBr/AcOH and treatment with Fmoc-OSu gave the trans-L-POPNA A monomer 7 in an overall yield of 48% from 2. In the case of the trans-L-POPNA C monomer, first, N 4 -benzyloxycarbonylcytosine (N 4 -Cbz-cytosine) 12 was introduced to 5 to give compound 8 in 40% yield. Next, Boc and tBu protecting groups of 8 were removed with TFA to avoid deprotection of the Cbz group. The resulting free compound was treated with Fmoc-OSu to give the trans-L-POPNA C monomer 9 in an overall yield of 29% from 2. In the case of the trans-L-POPNA G monomer, first, alkylation of 2-amino-6-chloropurine with 5 gavecompound 10 in 42% yield. Conversion of the 6-chloro group on 10 with 2-nitrophenoxy gave compound 11 in 86% yield. Next, the N 2 -amino group on 11 was protected with an isobutyryl group to avoid undesirable acylation in the peptidecoupling step, to give compound 12 in 93% yield. Subsequently, removal of the 2-nitrophenoxy group on 12 with 1,1,3,3-tetramethylguanidine gave compound 13 in 65% yield. 13 Finally, removal of Boc and tBu protecting groups with 30% HBr/AcOH and treatment with Fmoc-OSu gave the trans-L-POPNA G monomer 14 in an overall yield of 22% from 2.
All the final products (4, 7, 9, and 14) were characterized by 1 H-NMR, 13 C-NMR, HRMS, and RP-HPLC (See supplementary data). Other POPNA monomers of different configurations (cis-L-POPNA, trans-D-POPNA, and cis-D-POPNA monomers with A, T, G, and C nucleobases) were also synthesized from corresponding starting materials and characterized in a similar manner.
Scheme 1.
Synthetic routes of the trans-L-POPNA monomers 4, 7, 9, and 14: (i) HCOOH, DEAD, Ph 3 P, THF/Toluene, rt, overnight; (ii) 25% NH 3 aq, MeOH, rt, 1 h; (iii) N 3 -Benzoylthymine, DEAD, Ph 3 P, THF/Toluene, rt, overnight; (iv) 30% HBr/AcOH, rt, 30 min; (v) Fmoc-OSu, NaHCO 3 , H 2 O/MeCN (1/1, v/v) , rt, overnight; (vi) Ms-Cl, TEA, DCM, rt, 3 h; (vii) N 6 -Benzoyladenine, K 2 CO 3 , 18-Crown-6, DMF, 65 ˚C, overnight; (viii) N 4 -Cbz-cytosine, K 2 CO 3 , 18-Crown-6, DMF, 65 ˚C, overnight; (ix) TFA, rt, 30 min; (x) 2-NH 2 -6-Cl-Purine, K 2 CO 3 , 18-Crown-6, DMF, 65 ˚C, overnight; (xi) 2-Nitrophenol, DABCO, TEA, 1,2-dichloroethane, rt, overnight; (xii) iPrCOCl, pyridine, rt, overnight; (xiii) 2-Nitrobenzaldoxime, 1,1,3,3-tetramethylguanidine, MeCN, rt, overnight.
Trans-L-POPNA oligomers containing four types of nucleobases were synthesized by SPPS according to previous procedures. 5 The sequences of trans-L-POPNA oligomers were H-TGGTGCGAA-Lys-NH 2 (trans-L-POPNA9),
Fam-Sp2-TGGTGCGAATTC-Lys-NH 2 (Fam-trans-L-POPNA12, where Sp2 indicates a linker consisting of ethylene glycol units and Fam represents 5(6)-carboxy-fluorescein used as a fluorescent label), Fam-Sp2-TGGTGCCTC-Sp2-(Arg) 7 -NH 2 (Fam-trans-L-POPNA9-R7), and Fam-Sp2-CAGTTAGGGTTAG-Gly-NH 2 (Fam-trans-L-POPNA13). Lys, Arg, and Gly indicate lysine, arginine, and glycine, respectively. The N-terminals and Cterminals of these oligomers are primary amines and primary amides, respectively. The crude oligomers were purified by preparative HPLC, and the purified oligomers were identified by MALDI-TOF Mass (trans-L-POPNA9, calcd. 
Hybrid formation of POPNA oligomers with DNAs
Melting curves of trans-L-POPNA9 in equimolar mixtures with DNA (5′-TTCGXACCA-3′, X = A, T, G, and C) are shown in Figure 2 . In the case of the completely complementary DNA (X = C), the sigmoidal melting curve was observed having a melting temperature (T m ) of 22.2 ˚C. The T m 's of the hybrids of trans-L-POPNA9 with DNA sequences having a singlemismatched, where X = A, T, and G, were 21.4, 21.0, and 20.3 ˚C, respectively. These results indicate that trans-L-POPNA9, having a sequence that contains the four types of nucleobases, forms moderate sequence-specific hybrids with DNAs. 
˚C). Trans-L-POPNA13, cis-L-POPNA13 and cis-D-POPNA13
showed lower hybrid stabilities with the fully complementary DNA than trans-D-POPNA13. All POPNA oligomers formed moderate sequence-specific hybrids with DNAs. Successful hybridizations of all the stereoisomers of POPNA are explained in terms of their flexible main chains that contain ether linkages. However, the higher stability of the hybrid between trans-D-POPNA and DNA, than those of the other oligomers/DNA hybrids, is a consequence of its restricted main chain, which contains pyrrolidine rings. Moreover, hybrids of POPNA oligomers with DNAs are preferentially formed with antiparallel orientations, especially trans-L-POPNA13 and cis-L-POPNA13 (32.9 ˚C and 33.6 ˚C for antiparallel orientation and
28.6 ˚C and 27.3 ˚C for parallel orientation, respectively). This result also suggests that configurations of POPNA have a tendency to form a single, stable hybrid with DNA. 
Transport of POPNA oligomers into cytoplasm
We examined the internalization of the POPNA oligomer into Chinese hamster ovary (CHO) cells with confocal laser scanning microscopy. First, the CHO cells were cultured in the presence of 10 μM Fam-trans-L-POPNA12. However, no fluorescence was observed with the CHO cells. Unfortunately, the POPNA oligomer did not internalize into the cells by themselves. In the case of the trans-L-POPNA oligomer conjugated with a CPP (Fam-trans-L-POPNA9-R7), the fluorescence from Fam was observed inside the cells, as shown in Figure 3 . However, this image indicates that the fluorescence is mostly confined in small vesicular compartments. These endosomes were observed even after 6 h of incubation, without a decrease in fluorescence. These results suggest that the POPNA oligomer conjugated with a CPP internalized inside CHO cells by an endocytosis mechanism and that they remained inside the endosomes.
To release the POPNA oligomer from the endosomes, we synthesized an HA2 (Tmr-HA2-R7, a peptide that disrupts endosomes) 7 labeled with a 5 (6) 
Conclusions
In summary, we synthesized sixteen POPNA monomers with four types of nucleobases on four stereoisomers of the pyrrolidine rings. POPNA oligomers of a mixed sequence of four types of nucleobases were also synthesized. These POPNA oligomers were successfully hybridized with DNAs. The configurations of POPNA oligomers affect the hybridization. The POPNA oligomers were readily taken up inside the cytoplasm of CHO cells when mixed with a HA2-CPP conjugate. The antisense effect of the four types of stereoisomers of the POPNA oligomers, in combination with the HA2-CPPconjugate is now under investigation.
Experimental
General
Diethyl azodicarboxylate (DEAD), triphenylphosphine (Ph 3 P), methanesulfonylchloride (Ms-Cl), 25% aqueous ammonia, triethylamine (TEA), N 6 -benzoyladenine, 18-crown-6, 2-amino-6-chloropurine, 2-nitrophenol, 2-nitrobenzaldoxime, K 2 CO 3 , . DNA oligomers were purchased from Invitrogen Japan (Tokyo, Japan). These reagents were used without purification. Distilled water was used throughout the synthesis. 1 H-NMR and 13 C-NMR spectra were recorded on a Varian Mercury 300 spectrometer. High-resolution mass spectra were measured on Nihon Denshi MS 700. MALDI-TOF Mass spectra were measured on Applied Biosystems Voyager DE-Pro, and hybridization behavior was observed on a JASCO V-560 UV-vis spectrophotometer equipped with a temperature controller. Fluorescent images from confocal laser scanning microscopy were observed on Olympus FLUOVIEW FV-1000.
Key intermediates for POPNA monomers, 1 (trans-L configuration), cis-L-configurated 1(2), cis-D-configurated 1, and trans-D-configurated 1were synthesized according to procedures that were previously reported. 
Synthesis of POPNA T monomers 4.2.1. (2S,4R)-4-(3-Benzoyl-5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-2-tert-butoxycarbonylmethoxymethylpyrrolidine-1-carboxylic acid tert-butyl ester (3)
2 (3.51 g, 10.6 mmol), Ph 3 P (4.17 g, 15.9 mmol) , and N 3 -benzoylthymine (2.39 g, 10.6 mmol) were added to tetrahydrofuran (THF)(10 mL). To this mixture was added DEAD (2.49 mL, 15.9 mmol) under argon atmosphere at -15˚C and then stirred at room temperature overnight. The resultant mixture was evaporated to dryness and the residue was washed several times with 50/50 ethyl acetate (AcOEt)/hexane (Hex) mixture and dried in vacuo. The residue was chromatographed on silica gel with 40/60 AcOEt/Hex mixture as eluting solvent. The title compound 3 was obtained as white powder. Yield: 17%. R f (AcOEt/Hex = 5/5, v/v): 0.41.
1 H-NMR (300MHz, CDCl 3 ):δ1.5 (s+s, 18H, Boc CH 3 and tert-butyl CH 3 ), 1.96 (s, 3H, thymine CH 3 ), 2.2-2.6 (m, 2H, C3′H 2 ), 3.4-4.3 (m, 7H, C5′H 2 , C α -CH 2 -O-CH 2 -CO and C2′H), 5.2 (m, 1H, C4′H), 7.1 (s, 1H, C6H), 7.4-7.9 (m, 5H, phenyl). 3 (1.00 g, 1.83 mmol) was treated with 30% HBr/AcOH (10 mL) for 30 min at room temperature. The resultant mixture was evaporated to dryness. The residue was dissolved in 5% aqueous NaHCO 3 (10 mL) to adjust the pH to 8. A solution of Fmoc-OSu (0.71 g, 2.20 mmol) in acetonitrile (MeCN, 10 mL) was added to the aqueous solution with stirring under ice cooling. The reaction mixture was stirred at room temperature overnight and evaporated to dryness. The residue was dissolved in water and the aqueous layer was washed three times with diethyl ether (Et 2 O, each 30 mL), acidified to pH 7 with 5% aqueous KHSO 4 , and extracted three times with AcOEt. The AcOEt layer was washed with water and brine, then, dried over MgSO 4 . Filtration followed by solvent evaporation gave the title compound 4. 4 was obtained as a white powder. 4 was purified by preparatory RP-HPLC (C18 column) before using to SPPS. Yield: 60%. 1 
(2S,4R)-2-
Synthesis of POPNA A monomers
(2S,4S)-2-tert-Butoxycarbonylmethoxymethyl-4-methanesulfonyloxy-pyrrolidine-1-carboxylic acid tert-butyl ester (5)
Ms-Cl (2.5 g, 21.6 mmol) and TEA (2.2 g, 21.6 mmol) were added to a solution of 2 (5.5 g, 16.6 mmol) in dichloromethane (DCM, 17 mL) under ice cooling, and the mixture was stirred for 3 h at room temperature. The mixture was evaporated to dryness. The residue was dissolved in water (50 mL) and extracted three times with AcOEt (each 50 mL). The AcOEt layer was washed with water (50 mL) and brine (50 mL), then, dried over MgSO 4 , 154.0 (Boc amide), 169.5 (tert-butyl ester). 4.3.2(2S, 5 (2.5 g, 6.1 mmol) , N 6 -benzoyladeninne (2.9 g, 12 mmol), 18-crown-6-ether (1.0 g, 3.8 mmol), and K 2 CO 3 ( 1.6 g, 12 mmol) were added to N, N′-dimethylformamide (DMF, 10 mL). The mixture was stirred at 60˚C overnight. The mixture was evaporated to dryness. The residue was dissolved in water (50 mL) and extracted three times with AcOEt (each 50 mL). The AcOEt layer was washed with water (50 mL) and brine (50 mL), then, dried over MgSO 4 . Filtration followed by solvent evaporation gave crude yellow powder. The crude compound was chromatographed on silica gel with 90/10 AcOEt/Hex mixture as eluting solvent. The title compound 6 was obtained as a white powder. Yield: 41%. R f (AcOEt/Hex = 7/3 (v/v)): 0. 13 , 123 (C5), 127.8, 128.8, 132.7, and 133.6 (phenyl) , 129 (C6), 141.3 (C8) , 149.5 (C2) , 152.4 (C4) , 153.9 (Boc amide), 164.7 (benzoyl amide), 169.4 (tert-butyl ester).
4.3.3(2S,4R)-4-(6-Benzoylamino-purin-9-yl)-2-carboxymethoxymethyl-pyrrolidine-1-carboxylic acid 9H-fluoren-9-ylmethyl ester (7, trans-L-POPNA A monomer)
6 (1.4 g, 2.5 mmol) was treated with 30% HBr/AcOH (10 mL) for 30 min at room temperature. The resultant mixture was evaporated to dryness. The residue was dissolved in 5% aqueous NaHCO 3 (50 mL) to adjust the pH to 8. A solution of Fmoc-OSu (0.94 g, 2.8 mmol) in MeCN (50 mL) was added to the aqueous solution with stirring under ice cooling. The reaction mixture was stirred at room temperature overnight and evaporated to dryness. The residue was dissolved in water and the aqueous layer was washed three times with Et 2 O (each 30 mL), acidified to pH 7 with 5% aqueous KHSO 4 , and the resultant precipitate was collected by filtration. The residue was washed several times with water and dried in vacuo. 7 was obtained as a white powder. 7 was purified by preparatory RP-HPLC (C18 column) before using to SPPS. Yield: 77%.
1 H-NMR (300MHz, CDCl 3 ):δ2.4-3.2 (m, 3H, C3′H 2 and C2′H), 3.5-4.8 119.9, 124.9, 127.0, 127.7, 141.2, and 143.7 (Fmoc aromatic ring), 127.2, 128.4, 132.8, and 133.0 (phenyl) 2895, 1701, 1611, 1518, 1456, 1420, 1339, 1242, 1138 . Synthesis of cis-L-configuration of 7 was also performed in an identical manner to that described above. Yield: 89%.
1 H-NMR (300MHz, CDCl 3 ):δ2.3-3.2 (m, 3H, C3′H 2 and C2′H), 3.2-5.4 (m, 10H, Fmoc CH, C5′H 2 , C α -CH 2 -O-CH 2 -CO, Fmoc CH 2 and C4′H), 7.2-7.8 (m, 13H, Fmoc aromatic ring and phenyl), 7.96 (br, 1H, C8H), 8.76 and 8.86 (br+br, 1H, C2H, rotamer), 10.85 (br, 1H, COOH) . 13 C-NMR (75 MHz, CDCl 3 ):δ 32.9 (C3′), 47.2 (Fmoc CH), 51.5 (C5′), 52 (C4′), 55.8 (C2′), 67.2 (Fmoc CH 2 ), 67.9 (O-CH 2 -CO), 71.6 (C α -CH 2 -O), 119.9, 124.7, 127.1, 127.7, 141.3, and 143.8 (Fmoc aromatic ring) , 128.5 (C5) , 127.4, 128.2, 132.7, and 133.1 (phenyl) , 142.5 (C8) 4.4.1. ( (8) 5 (2.00 g, 4.88 mmol) , N 4 -Cbz-cytosine (2.99 g, 12. 2 mmol), 18-crown-6 (3.22 g, 12.2 mmol) and K 2 CO 3 ( 1.68 g, 12. 2 mmol) were added to DMF (50 mL) and stirred at 65 ˚C overnight. The mixture was filtered and evaporated dryness. The crude oil was chromatographed on silica gel with 70/30 AcOEt/Hex mixture as eluting solvent. The title compound 8 was obtained as a colorless viscous oil. Yield: 40%.
Synthesis of POPNA C monomers
2S,4R)-4-(4-Benzyloxycarbonylamino-2-oxo-2H-pyrimidin-1-yl)-2-tert-butoxycarbonylmethoxymethyl-pyrrolidine-1-carboxylic acid tert-butyl ester
1 H-NMR (300MHz, CDCl 3 ):δ1.44 and 1.47 (s+s, 18H, Boc CH 3 and tert-butyl CH 3 ), 2.35 and 2.55 (m+m, 2H, C3′H 2 ), 3.4-4.3 (m, 7H, C5′H 2 , C α -CH 2 -O-CH 2 -CO, and C2′H), 5.21 (s, 2H, Cbz CH 2 ), 5.28 (m, 1H, C4′H), 7.1-7.9 (m, 8H, C6H, phenyl, C5H, and Cbz ester). (9, 8 (0.50 g, 0.89 mmol) was treated with TFA(10mL) for 30 min at room temperature. The resultant mixture was evaporated to dryness. The residue was dissolved in 5% aqueous NaHCO 3 (50 mL) to adjust the pH to 8. A solution of 0.98 mmol) in MeCN (50 mL) was added to the aqueous solution with stirring under ice cooling. The reaction mixture was stirred at room temperature overnight and evaporated to dryness. The residue was dissolved in water and the aqueous layer was washed three times with Et 2 O (each 30 mL), acidified to pH 3 with 5% aqueous KHSO 4 , and extracted three times with AcOEt (each 50 mL). The AcOEt layer was washed with water (50 mL) and brine (50 mL) and dried over MgSO 4 . Filtration followed by solvent evaporation gave the title compound 9. 9 was obtained as a white powder. 9 was purified by preparatory RP-HPLC (C18 column) before using to SPPS. Yield: 54%.
(2S,4R)-4-(4-Benzyloxycarbonylamino-2-oxo-2H-pyrimidin-1-yl)-2-carboxymethoxymethyl-pyrrolidine-1-carboxylic acid 9H-fluoren-9-ylmethyl ester
1 H-NMR (300MHz, CDCl 3 ):δ2.1-3.2 (m, 3H, C3′H 2 and C2′H), 9H, Fmoc CH, C5′H 2 , C α -CH 2 -O-CH 2 -CO, and Fmoc CH 2 ), 5.22 (s, 2H, Cbz CH 2 ), 5.30 (m, 1H, C4′H), 15H, C6H, Fmoc aromatic ring, phenyl, and C5H) , 9.25 (br, 1H, COOH) . 13 96.0 (C5), 119.9, 124.8, 127.1, 127.7, 141.2, and 143.7 (Fmoc aromatic ring) , 124.4, 128.1, 128.5, and 135.0 (phenyl) , 145.5 (C6), 152.8 (Cbz ester), 154.3 (Fmoc amide) , 154.9 (C2) , 162.2 (C4) , 172.8 (COOH) . HRMS (found/calculated): 625.2314/625.2220 [M+H] + .
Synthesis of cis-L-configuration of 9 was also performed in an identical manner to that described above. 96.3 (C5) , 120.0, 124.8, 126.9, 127.1, 141.3, and 143.8 (Fmoc aromatic ring), 124, 127.8, 128.3, and 134.8 (phenyl) , 148.6 (C6) 1697, 1624, 1558, 1508, 1452, 1429, 1400, 1354, 1253, 1140, 1124, 1071, 1005 . Synthesis of trans-D-configuration of 9 and cis-D-configuration of 9 were performed according to aforementioned protocols and these spectroscopic data were identical with 9 and cis-L-configuration of 9, respectively. Trans-D-configuration of 9; Yield: 5% at 2 steps. HRMS (found/calculated): 625.2323/625.2220 1701, 1654, 1628, 1558, 1521, 1450, 1420, 1352, 1331, 1142, 1103, 1069, 993, 974. 4.5 . Synthesis of POPNA G monomers 4.5.1. (2S, 5 (5.0 g, 12.4 mmol), 2-amino-6-chloropurin (6.3 g, 37.1 mmol), 18-crown-6-ether (9.8 g, 37.1 mmol), and K 2 CO 3 (5.1 g, 37.1 mmol) were added to DMF (50 mL) and stirred at 65 ˚C overnight. The mixture was filtered and evaporated to dryness. The mixture was added to AcOEt and the insoluble residue was removed. The crude oil was chromatographed on silica gel with 70/30AcOEt/Hex mixture as the eluting solvent. The title compound 10 was obtained as a colorless viscous oil. Yield: 36%. 1 33.4 and 34.6 (C3′) , 50.5 and 51.2 (C5′), 52.8 and 53.5 (C4′) , 55.9 (C2′) , 68.9 (O-CH 2 -CO), 71.9 (C α -CH 2 -O), , 125.5 (C5) , 140.5 (C8) , 151.4 (C2) , 153.5 (Boc amide), 158.9 (C4), 162.5 (C6), 169.3 (tert-butyl ester).
(2S,4R)-4-[2-Amino-6-(2-nitro-phenoxy)-purin-9-yl]-2-tert-butoxycarbonylmethoxymethyl-pyrrolidine-1-carboxylic acid tert-butyl ester (11)
. DABCO (0.46 g, 4.15 mmol) and TEA (1.26 g, 12. 45 mmol) were added to a solution of 10 (2.00 g, 4.15 mmol) in 1,2-dichloroethane (20 mL) and the mixture was stirred at room temperature overnight. The mixture was evaporated to dryness. The residue was dissolved in water (100 mL) and extracted three times with DCM (each 50 mL). The DCM layer was washed with water (100 mL) and brine (100 mL), and it was then dried over MgSO 4 . Filtration followed by solvent evaporation gave crude viscous oil. The crude oil was chromatographed on silica gel with 70/30AcOEt/Hex mixture as the eluting solvent. The title compound 11 was obtained as a yellow crystal. Yield: 78%.
1 H-NMR (300 MHz, CDCl 3 ):δ1.45 and 1.47 (s+s, 18H, Boc CH 3 and tert-butyl CH 3 ), 2.62 (m, 2H, C3′H 2 ), 3.5-4.4 (m, 7H, C2′H, C5′H 2 and C α -CH 2 -O-CH 2 -CO), 4.84 (br, 2H , NH 2 ), 5.16 (m, 1H, C4′H), 7.41, 7.67, and 8.09 (t+t+d, 4H, phenyl) , 7.69 (s, 1H, C8H). 13 C-NMR (75 MHz, CDCl 3 ):δ 28. 1 and 28.4 (Boc CH 3 and tert-butyl CH 3 ), 33.4 and 34.7 (C3′) , 51.3 (C5′) , 52.6 and 53.2 (C4′) , 55.9 (C2′) , 115.6 (C5) , 125.3, 125.5, 126.0, 134.5, 142.5, and 145.5 (phenyl) , 138.9 (C8) , 155.2 and 158.5 (C2 and C6) , 154.1 (Boc amide), 159.1 (C4), 169.4 (tert-butyl ester) . 4.5.3. (2S, .11 (1.9 g, 3.2 mmol) was dissolved in pyridine and iPrCOCl (0.42 g, 3.9 mmol) was added to the solution of 11 in pyridine (20 mL) under ice cooling and the mixture was stirred at room temperature overnight. The mixture was then evaporated to dryness. The residue was added to water (100 mL) and extracted three times with AcOEt (each 100 mL). The AcOEt layer was washed with 5% aqueous citric acid (100 mL) and water (100 mL), and it was then dried over MgSO 4 . Filtration followed by solvent evaporation gave crude viscous oil. The crude oil was chromatographed on silica gel with 70/30AcOEt/Hex mixture as the eluting solvent. The title compound 12 was obtained as yellow foam. Yield: quant.
1 H-NMR (300 MHz, CDCl 3 ):δ1.03 and 1.05 (d, 6H, ), 1.46 and 1.48 (s+s, 18H, Boc CH 3 and tert-butyl CH 3 ), 2.6-2.8 (m, 2H, C3′H 2 ), 3.16 (m, 1H, , 3.6-4.3 (m, 7H, C2′H, C5′H 2 and C α -CH 2 -O-CH 2 -CO), 5.32 (m, 1H, C4′H), 7.4-8.2 (m+m+d, 5H, phenyl and C8H), 7.92 (s, 1H, iso-butyl amide). 13 C-NMR (75 MHz, CDCl 3 ):δ 18.8 (iso-butyl CH 3 ), 28.1 and 28.4 (Boc CH 3 and tert-butyl CH 3 ), 33.5 (C3′), , 51.3 (C5′) , 53.8 (C4′) , 55.9 (C2′) , 68.9 (O-CH 2 -CO), 71.9 and 72.5 (C α -CH 2 -O), , 118.0 (C5), 125.5, 125.8, 126.6, 134.8, 142.2, and 145.5 (phenyl) -pyrrolidine-1-carboxylic acid tert-butyl ester (13) . 12 (2.2 g, 3.3 mmol) and 2-nitrobenzaldoxime (5.5 g, 33 mmol) were dissolved in MeCN (30 mL), and 1,1,3,3-tetramethylguanidine (3.5 g, 30 mmol) was added to the solution. The mixture was stirred at room temperature overnight. The mixture was evaporated to dryness. The residue was dissolved in water (100 mL) and extracted five times with DCM (each 100 mL). The DCM layer was washed with water (100 mL) and brine (100 mL), and it was then dried over MgSO 4 . Filtration followed by solvent evaporation gave a crude viscous oil. The crude oil was chromatographed on silica gel with 95/5AcOEt/MeOH mixture as the eluting solvent. The title compound 13 was obtained as a white powder. Yield: 50%. 1 H-NMR (300 MHz, CDCl 3 ):δ1.22 and 1.24 (d, 6H, ), 1.42 and 1.45 (s+s, 18H, Boc CH 3 and tert-butyl CH 3 ), 2.4-2.8 (m, 3H, C3′H 2 and iso-butyl CH), 3.5-4.3 (m, 7H, C2′H, C5′H 2 and C α -CH 2 -O-CH 2 -CO), 5.02 (m, 1H, C4′H), 7.61 (s, 1H, C8H), 9.37 (br, 1H, iso-butyl amide), 12. 08 (br, 1H, C1H). 13 C-NMR (75 MHz, CDCl 3 ):δ 18.9 and 19.0 (iso-butyl CH 3 ), 28.1 and 28.4 (Boc CH 3 and tert-butyl CH 3 ), 34.0 (C3′), 36.3 (isobutyl CH) , 50.9 (C5′), 52.1 (C4′), 56.0 (C2′), 68.9 (O-CH 2 -CO), 71.9 (C α -CH 2 -O), , 121.6 (C5), 137.2 (C8), 147.3 and 148.1 (C2 and C6), 154.3 (Boc amide) , 155.7 (C4) , 169.6 (tert-butyl ester) , 178.8 (iso-butyl amide). 4.5.5. (2S, . 13 (0.9 g, 1.6 mmol) was treated with 30% HBr/AcOH (10 mL) for 30 min at room temperature. The resultant mixture was evaporated to dryness. The residue was dissolved in 5% aqueous NaHCO 3 to adjust the pH to 8 (30 mL). A solution of Fmoc-OSu
(2S,4R)-2-tert-
